Accumetrics,
Inc.
|
|
Accumetrics, Inc. Appoints William Dippel as Executive Vice
President of Operations and R&D
Timothy I. Still Appointed CEO at Accumetrics
Anthony Arnerich appointed Executive Chairman at Accumetrics
Accumetrics Announces The Launch and First Patient Enrolled
into the GRAVITAS Trial
Accumetrics Announces $28.8 Million Financing and Initiation
of Pivotal Clinical Trial
back to top |
Alereon, Inc. |
|
Alereon AL5000 Family PHY Certified for WiMedia Bandgroup 6
Alereon Announces Acquisition of Wireless USB Driver
Technology
Alereon Powers New Toshiba Worldwide Wireless USB Solutions
for Home and Office
Samsung Introduces NaBee the Worldwide Wireless USB
Solutions for Digital Cameras Powered by Alereon Worldwide
Wireless USB Chipset
Alereon Announces FCC Certification for Worldwide Wireless
USB Adapter
back to top |
Apollo Endosurgery,
Inc. |
|
Apollo Endosurgery Announces 510(k) Clearance for its
Flexible Endoscopic Suturing System
Surgery Without the Slicing
The Bleeding Edge: The drugs giants are in trouble, but medical devices are
blooming
back to top |
| Asuragen,
Inc. |
|
Asuragen Adds NuGEN Ovation® Systems to Gene Expression
Profiling Menu for RNA Amplification and Target Preparation
Asuragen® Signs Armored RNA® Licensing Agreement with Focus
Diagnostics
Asuragen, Inc. Launches Signature® NPM1 Mutations (RUO)*:
A Rapid Multiplex Assay for the Detection of NPM1 Mutations
Affymetrix and Asuragen Sign Agreement to Develop IVT
Reagent Kits for Molecular Diagnostic Applications
back to top
|
| BioForm
Medical, Inc. (NASDAQ: BFRM) |
|
338 Patient Pivotal Trial Demonstrates Safety and
Effectiveness of Polidocanol Sclerotherapy Product for
Varicose Vein Treatment
The Realities of Radiesse in Cosmetic Corrections - Doctors, We Can Stand Up
and Applaud
Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic
Surgery Special Issue on Fillers
CryoLife's BioGlue® Surgical Adhesive Receives European
Approval for use in Browlift Cosmetic and Reconstructive
Plastic Surgery
back to top
|
| BioMimetic
Pharmaceuticals, Inc. ("BMTI") (NASDAQ: BMTI) |
Dr. Samuel E. Lynch Presides Over the NASDAQ
Closing Bell to Celebrate
the Initial Public Offering of BioMimetic Therapeutics, Inc. [BMTI]
back
to top |
| BioSurface
Engineering
Technologies,
Inc. ("BioSET") |
Tornier and Bioset Enter Synthetic Growth Factor Pact
Synthetic Peptide That Enhances the Effect of a Bone Growth Factor,
BMP-2
back
to top
|
| Calcitec Biomaterial Solutions,
Inc. |
| back
to top |
| Cameron Health, Inc. |
|
Internal External Defibrillator: A new device may offer a
safer way to jump-start ailing hearts
back
to top |
| Cardiva Medical, Inc. |
Global Vascular Closure Device Market to Exceed $900 Million by 2013
Cardiva Medical, Inc. to Present at the 'Investment In Innovation (In3)
Medical Device Summit' on June 18, 2008 in San
Francisco, CA; Announces the
Completion of Its Latest Phase in Its US Sales Force Expansion
Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
back
to top |
| GlycoMimetics,
Inc. ("GMI") |
|
GlycoMimetics, Inc. Commences Phase 1 Clinical Trial of Lead
Drug Candidate
GlycoMimetics, Inc. to Present Results of Lead Candidate in Animal
Models of Sickle Cell Disease at American Society of Hematology Annual
Meeting
back to top |
| IDEV
Technologies, Inc. |
IDev(R) Technologies Inc. Announces Distribution Partnership with YMed Inc.
for the VascuTrak 2(TM) Focal Force PTA Catheter
Wire-Interwoven Nitinol: A new class of stents may expand treatment options
for patients with peripheral arterial disease
back to top |
| InSite Vision, Inc.
("ISV") (AMEX: ISV) |
|
InSite Vision Names Louis Drapeau Interim CEO & Dr. Evan
Melrose Named Chairman of the Board
InSite Vision and PTV Sciences Announce Preliminary Voting
Results at Annual Meeting
InSite Vision Signs AzaSite(R) Licensing and Distribution Agreement with
Essex Bio-Technology for People's Republic of China
InSite Vision adds Turkish distributor for AzaSite
back to top |
| LDR
Spine USA, Inc. ("LDR") |
LDR Announces Release of its ROI-A™ Anterior Lumbar Partial Vertebral Body
Replacement Device
LDR Announces Release of its ROI-T™ Transforaminal Approach Implant
LDR Launches verteBRIDGE™ Anchoring Technology for Spinal Applications
back
to top |
| On-X® Life Technologies, Inc. |
Examination of
hemolytic potential with the On-X(R) prosthetic heart valve
Austin-Based Medical Carbon Research Institute, LLC. Becomes On-X Life
Technologies, Inc.
back
to top |
| OsteoBiologics, Inc. ("OBI") (NYSE: SNN)
- Acquired by: Smith & Nephew |
Smith &
Nephew Acquires OBI, Inc.
back
to top |
| Sinexus, Inc. |
Sinexus Welcomes New CEO and Completes Series B
back
to top
|
| Tryton Medical, Inc. |
|
Tryton Medical introduces Side Branch Stent System in Europe
Tryton Medical Announces Two Key Hires and Relocation to
Research Triangle Park, N.C
Tryton Medical Appoints VP Sales & Marketing EU
Tryton Medical Appoints President and CEO
Tryton Medical, Inc. Closes $14 Million Financing
back
to top |
| ZIOPHARM Oncology, Inc. (NASDAQ:
ZIOP) |
|
ZIOPHARM Presents Darinaparsin Molecular Mechanism of Action
and Preliminary Oral Administration Phase I Clinical Data at
the EORTC-NCI-AACR Symposium
ZIOPHARM Receives Orphan Medicinal Product Designation for
Palifosfamide (ZIO-201) in the Treatment of Soft Tissue
Sarcoma
ZIOPHARM Commences Randomized Phase II Study of
Palifosfamide in Soft Tissue Sarcoma
ZIOPHARM Announces Organizational Changes and New Appointments in Clinical
and Regulatory
ZIOPHARM Receives Notices of Allowance for Two U.S. Patent Applications
Covering Darinaparsin
back
to top |
| |
| |
| |
|
